Evidence map›Paper›PMID 37346103›Full record

ArticleFrontiers in public health2023

A COVID-19 isolation facility for people experiencing homelessness in Berlin, Germany: a retrospective patient record study.

Merle Hörig, Sarah M Klaes, Svetlana Krasovski-Nikiforovs, Welmoed van Loon, Lukas Murajda, Rosa C O Rodriguez, Christine Schade, Anabell Specht, Gabriela Equihua Martinez, Ruth Zimmermann and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Merle HörigCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sarah M KlaesBerliner Stadtmission, Berlin, Germany.
Svetlana Krasovski-NikiforovsBerliner Stadtmission, Berlin, Germany.
Welmoed van LoonCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Lukas MurajdaHealth Authority Berlin-Mitte, Berlin, Germany.
Rosa C O RodriguezHealth Authority Berlin-Mitte, Berlin, Germany.
Christine SchadeHealth Authority Berlin-Mitte, Berlin, Germany.
Anabell SpechtCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Gabriela Equihua MartinezCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ruth ZimmermannDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Frank P MockenhauptCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Joachim SeyboldMedical Directorate, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Andreas K LindnerCharité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Navina SarmaDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: People experiencing homelessness (PEH) are disproportionately affected by the COVID-19 pandemic. For many PEH it is impossible to isolate due to the lack of permanent housing. Therefore, an isolation facility for SARS-CoV-2 positive PEH was opened in Berlin, Germany, in May 2020, offering medical care, opioid and alcohol substitution therapy and social services. This study aimed to assess the needs of the admitted patients and requirements of the facility. Materials and methods: This was a retrospective patient record study carried out in the isolation facility for PEH in Berlin, from December 2020 to June 2021. We extracted demographic and clinical data including observed psychological distress from records of all PEH tested positive for SARS-CoV-2 by RT-PCR. Data on duration and completion of isolation and the use of the facilities' services were analyzed. The association of patients' characteristics with the completion of isolation was assessed by Student's Results: A total of 139 patients were included in the study (89% male, mean age 45 years, 41% with comorbidities, 41% non-German speakers). 81% of patients were symptomatic (median duration 5 days, range 1-26). The median length of stay at the facility was 14 days (range 2-41). Among the patients, 80% had non-COVID-19 related medical conditions, 46% required alcohol substitution and 17% opioid substitution therapy. Three patients were hospitalized due to low oxygen saturation. No deaths occurred. Psychological distress was observed in 20%, and social support services were used by 65% of PEH. The majority (82%) completed the required isolation period according to the health authority's order. We did not observe a statistically significant association between completion of the isolation period and sociodemographic characteristics. Conclusion: The specialized facility allowed PEH a high compliance with completion of the isolation period. Medical care, opioid and alcohol substitution, psychological care, language mediation and social support are essential components to address the specific needs of PEH. Besides contributing to infection prevention and control, isolation facilities may allow better access to medical care for SARS-CoV-2 infected PEH with possibly positive effects on the disease course.

Indexed as

COVID-19Ill-Housed PersonsAnalgesics, OpioidBerlinEthanolFemaleGermanyHumansMaleMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2Analgesics, OpioidEthanolCOVID-19homelessnesshomeless shelterisolation and infection controlisolation facilitypeople experiencing homelessnessSARS-CoV-2

Identifiers

PMID37346103
PMCPMC10281190
OpenAlexW4379518299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.